Cerulean Pharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cerulean Pharma Inc
TickerDARE
CIK #0001401914
CUSIP23666P101
SectorLife Sciences - Pharmaceutical Preparations
Address840 Memorial Drive 5th Floor, Cambridge, MA 02139
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Dare Bioscience Inc 2024-11-22 Exemption: 506(b) · Remaining: $15,000,000 · Duration: More than one year · Revenue: Decline to Disclose
Cerulean Pharma Inc 2016-10-17 0.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001401914] 10-K
[0001401914] 10-Q
[0001401914] 3
[0001401914] 4
[0001401914] 8-K
[0001401914] D
[0001401914] SC 13D
[0001401914] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Law Custodial Inc Dare Bioscience Inc [2025-10-06] 0.0
Vanguard Group Inc Dare Bioscience Inc [2021-02-10] 7.88
Vanguard Index Funds Dare Bioscience Inc [2021-02-08] 7.11
Polaris Venture Partners III LP Dare Bioscience Inc [2020-02-12] 4.7
Hudson Bay Capital Management LP Dare Bioscience Inc [2019-02-01] 5.64
CVI Investments Inc Dare Bioscience Inc [2018-02-22] 8.8
Empery Asset Management LP Dare Bioscience Inc [2018-02-21] 0.05
Johnson Sabrina Martucci Dare Bioscience Inc [2017-07-28] 11.0
Hawley Roger Dare Bioscience Inc [2017-07-28] 11.0
Walters-Hoffert Lisa Dare Bioscience Inc [2017-07-28] 11.0
Walters Mark Dare Bioscience Inc [2017-07-28] 11.0
Dare Bioscience Inc Cerulean Pharma Inc [2017-03-28] 20.7
Lilly Eli & Co Cerulean Pharma Inc [2015-02-17] 11.7
CVF LLC Cerulean Pharma Inc [2015-02-17] 11.2
FMR LLC Cerulean Pharma Inc [2014-05-12] 0.0
Venrock Partners V L P Cerulean Pharma Inc [2014-04-25] 15.9
Crane Alan L Cerulean Pharma Inc [2014-04-21] 25.3
Polaris Venture Partners V LP Cerulean Pharma Inc [2014-04-21] 16.7
Polaris Venture Partners IV LP Cerulean Pharma Inc [2014-04-21] 7.4
Lux Ventures II LP Cerulean Pharma Inc [2014-04-18] 4.5
Form 3/4/5 Filer 2011 - 2026
Dare Bioscience Inc
Grossman Jessica D
Steele Robin Joan
Rastetter William H
Matz Gregory W
Kelley Susan L
Johnson Sabrina Martucci
Haring-Layton MarDee
Fair John A
Ononye-Onyia Sophia Nnenna
Blanchard Cheryl R
Walters-Hoffert Lisa
Hawley Roger
Friedman Paul A
Carvajal Alejandra
Senderowicz Adrian
ONeill James E
Guiffre Christopherd T
Eliasof Scott
Beloff Gregg
Arbuckle Stuart A
Walt David R
Parkinson David Ross
McKee William
Hall Steven Edward
Crane Alan L
Tepper Robert I
Sasisekharan Ram
CVF LLC
Garmey Edward Graeme
Roberts Karen Lynn
Fetzer Oliver
Venrock Entrepreneurs Fund V LP
Venrock Associates V LP
Venrock Management V LLC
Venrock Partners Management V LLC
VEF Management V LLC
Venrock Partners V L P
Lilly Eli & Co
Lilly Ventures Fund I LLC
Polaris Venture Partners Entrepreneurs' Fund V LP
Polaris Venture Partners V LP
Polaris Venture Partners Special Founders' Fund V LP
Polaris Venture Management Co V LLC
Polaris Venture Partners Founders' Fund V LP
Polaris Venture Partners IV LP
Polaris Venture Partners Entrepreneurs Fund IV LP
Polaris Venture Management Co IV LLC
Lux Capital Management LLC
Lux Ventures II Partners Fund I LLC
Lux Venture Associates II LLC
Lux Ventures II Sidecar LP
Lux Ventures II LP
Rock Springs Capital Management LP
Deer VII & Co Ltd
Deer VII & Co LP
Bessemer Venture Partners VII Institutional LP
Bessemer Venture Partners VII LP
Lux Venture Partners II LP
Crane Howard R
Crane Family Irrevocable Trust- 2002
Sengupta Shiladitya
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Johnson Sabrina Martucci
Common Stock Warrant (right to buy) · derivative
2026-02-18 Grant 21,600
Johnson Sabrina Martucci
Series A Convertible Preferred Stock · derivative
2026-02-18 Grant 10,800
Johnson Sabrina Martucci
Employee Stock Option (right to buy) · derivative
2026-01-30 Grant 172,000 $0.00
Haring-Layton MarDee
Employee Stock Option (right to buy) · derivative
2026-01-30 Grant 49,000 $0.00
Employee Stock Option (right to buy) · derivative
2025-09-04 Grant 57,000 $0.00
Grossman Jessica D
Stock Option (right to buy) · derivative
2025-07-09 Grant 4,500 $0.00
Rastetter William H
Stock Option (right to buy) · derivative
2025-07-09 Grant 4,500 $0.00
Steele Robin Joan
Stock Option (right to buy) · derivative
2025-07-09 Grant 4,500 $0.00
Matz Gregory W
Stock Option (right to buy) · derivative
2025-07-09 Grant 4,500 $0.00
Kelley Susan L
Stock Option (right to buy) · derivative
2025-07-09 Grant 4,500 $0.00
Haring-Layton MarDee
Employee Stock Option (right to buy) · derivative
2025-01-28 Grant 38,000 $0.00
Johnson Sabrina Martucci
Employee Stock Option (right to buy) · derivative
2025-01-28 Grant 107,000 $0.00
Grossman Jessica D
Stock Option (right to buy) · derivative
2024-06-05 Grant 40,000 $0.00
Steele Robin Joan
Stock Option (right to buy) · derivative
2024-06-05 Grant 40,000 $0.00
Rastetter William H
Stock Option (right to buy) · derivative
2024-06-05 Grant 40,000 $0.00
Kelley Susan L
Stock Option (right to buy) · derivative
2024-06-05 Grant 40,000 $0.00
Matz Gregory W
Stock Option (right to buy) · derivative
2024-06-05 Grant 40,000 $0.00
Johnson Sabrina Martucci
Employee Stock Option (right to buy) · derivative
2024-03-12 Grant 750,000 $0.00
Fair John A
Employee Stock Option (right to buy) · derivative
2024-03-12 Grant 290,000 $0.00
Haring-Layton MarDee
Employee Stock Option (right to buy) · derivative
2024-03-12 Grant 290,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 26 1,024,822
2025-12-31 27 986,261
2025-09-30 21 1,009,190
2025-06-30 25 904,357
2025-03-31 25 827,009
2024-12-31 26 777,224
2024-09-30 23 655,380
2024-06-30 29 7,217,602
2024-03-31 37 6,825,087
2023-12-31 36 6,617,407
2023-09-30 31 12,928,425
2023-06-30 29 6,507,540
Form 13F Holdings
Firm Period DFND Voting Shares
Farther Finance Advisors LLC [2026-06-30] SOLE 0 9,450
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com